RaySearch Laboratories AB (publ) (RAY-B) - Net Assets

Latest as of September 2025: Skr919.30 Million SEK ≈ $98.93 Million USD

Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has net assets worth Skr919.30 Million SEK (≈ $98.93 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr1.94 Billion ≈ $209.24 Million USD) and total liabilities (Skr1.02 Billion ≈ $110.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RaySearch Laboratories AB (publ) liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr919.30 Million
% of Total Assets 47.28%
Annual Growth Rate 19.77%
5-Year Change 26.26%
10-Year Change 174.39%
Growth Volatility 33.5

RaySearch Laboratories AB (publ) - Net Assets Trend (2003–2024)

This chart illustrates how RaySearch Laboratories AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore RaySearch Laboratories AB (publ) asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for RaySearch Laboratories AB (publ) (2003–2024)

The table below shows the annual net assets of RaySearch Laboratories AB (publ) from 2003 to 2024. For live valuation and market cap data, see RaySearch Laboratories AB (publ) market cap and net worth.

Year Net Assets Change
2024-12-31 Skr876.71 Million
≈ $94.35 Million
+19.24%
2023-12-31 Skr735.23 Million
≈ $79.12 Million
+11.88%
2022-12-31 Skr657.16 Million
≈ $70.72 Million
+1.21%
2021-12-31 Skr649.28 Million
≈ $69.87 Million
-6.49%
2020-12-31 Skr694.35 Million
≈ $74.72 Million
-1.58%
2019-12-31 Skr705.47 Million
≈ $75.92 Million
+7.30%
2018-12-31 Skr657.45 Million
≈ $70.75 Million
+13.27%
2017-12-31 Skr580.42 Million
≈ $62.46 Million
+26.13%
2016-12-31 Skr460.19 Million
≈ $49.52 Million
+44.03%
2015-12-31 Skr319.52 Million
≈ $34.39 Million
+27.02%
2014-12-31 Skr251.55 Million
≈ $27.07 Million
+27.95%
2013-12-31 Skr196.60 Million
≈ $21.16 Million
-9.63%
2012-12-31 Skr217.55 Million
≈ $23.41 Million
+10.60%
2011-12-31 Skr196.70 Million
≈ $21.17 Million
-0.03%
2010-12-31 Skr196.76 Million
≈ $21.17 Million
+6.44%
2009-12-31 Skr184.86 Million
≈ $19.89 Million
+22.88%
2008-12-31 Skr150.44 Million
≈ $16.19 Million
+9.13%
2007-12-31 Skr137.85 Million
≈ $14.83 Million
+16.75%
2006-12-31 Skr118.07 Million
≈ $12.71 Million
+44.25%
2005-12-31 Skr81.85 Million
≈ $8.81 Million
+150.13%
2004-12-31 Skr32.72 Million
≈ $3.52 Million
+65.10%
2003-12-31 Skr19.82 Million
≈ $2.13 Million
--

Equity Component Analysis

This analysis shows how different components contribute to RaySearch Laboratories AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 86195200000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Skr856.93 Million 97.74%
Common Stock Skr17.14 Million 1.96%
Other Comprehensive Income Skr662.00K 0.08%
Other Components Skr1.98 Million 0.23%
Total Equity Skr876.71 Million 100.00%

RaySearch Laboratories AB (publ) Competitors by Market Cap

The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their market capitalization.

Company Market Cap
S.J.S. Enterprises Limited
NSE:SJS
$625.50 Million
Shenzhen Asiantime International Construction Co Ltd
SHE:002811
$625.51 Million
Dap Gayrimenkul Gelistirme AS
IS:DAPGM
$625.58 Million
Zhongjin Irradiation Incorporated Company
SHE:300962
$625.83 Million
Zhongrui Co Ltd
SHE:301587
$625.20 Million
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
$625.02 Million
Daewoong
KO:003090
$624.88 Million
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
$624.71 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in RaySearch Laboratories AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 735,232,000 to 876,707,000, a change of 141,475,000 (19.2%).
  • Net income of 203,513,000 contributed positively to equity growth.
  • Dividend payments of 68,566,000 reduced retained earnings.
  • Other comprehensive income increased equity by 6,527,999.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Skr203.51 Million +23.21%
Dividends Paid Skr68.57 Million -7.82%
Other Comprehensive Income Skr6.53 Million +0.74%
Other Changes Skr1.00 +0.0%
Total Change Skr- 19.24%

Book Value vs Market Value Analysis

This analysis compares RaySearch Laboratories AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 7.38x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 326.38x to 7.38x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-12-31 Skr0.58 Skr188.70 x
2004-12-31 Skr0.95 Skr188.70 x
2005-12-31 Skr2.39 Skr188.70 x
2006-12-31 Skr3.43 Skr188.70 x
2007-12-31 Skr4.00 Skr188.70 x
2008-12-31 Skr4.39 Skr188.70 x
2009-12-31 Skr5.39 Skr188.70 x
2010-12-31 Skr5.74 Skr188.70 x
2011-12-31 Skr5.74 Skr188.70 x
2012-12-31 Skr6.40 Skr188.70 x
2013-12-31 Skr5.77 Skr188.70 x
2014-12-31 Skr7.34 Skr188.70 x
2015-12-31 Skr9.32 Skr188.70 x
2016-12-31 Skr13.42 Skr188.70 x
2017-12-31 Skr16.93 Skr188.70 x
2018-12-31 Skr19.18 Skr188.70 x
2019-12-31 Skr20.58 Skr188.70 x
2020-12-31 Skr20.25 Skr188.70 x
2021-12-31 Skr18.94 Skr188.70 x
2022-12-31 Skr19.17 Skr188.70 x
2023-12-31 Skr21.45 Skr188.70 x
2024-12-31 Skr25.57 Skr188.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently RaySearch Laboratories AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 23.21%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 17.07%
  • • Asset Turnover: 0.57x
  • • Equity Multiplier: 2.39x
  • Recent ROE (23.21%) is above the historical average (13.29%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 -25.34% -22.68% 0.72x 1.55x Skr-7.01 Million
2004 39.43% 32.68% 0.87x 1.39x Skr9.63 Million
2005 35.60% 41.72% 0.65x 1.31x Skr20.96 Million
2006 30.68% 52.51% 0.47x 1.24x Skr24.41 Million
2007 14.35% 30.57% 0.37x 1.26x Skr5.99 Million
2008 12.11% 29.07% 0.33x 1.25x Skr3.18 Million
2009 16.31% 36.02% 0.36x 1.26x Skr11.66 Million
2010 14.69% 24.54% 0.46x 1.30x Skr9.22 Million
2011 8.65% 13.49% 0.48x 1.33x Skr-2.66 Million
2012 9.13% 10.91% 0.62x 1.35x Skr-1.89 Million
2013 -10.60% -10.19% 0.68x 1.52x Skr-40.50 Million
2014 23.79% 20.98% 0.73x 1.55x Skr34.68 Million
2015 21.97% 17.66% 0.82x 1.52x Skr38.26 Million
2016 32.90% 28.49% 0.74x 1.56x Skr105.39 Million
2017 20.27% 20.10% 0.64x 1.58x Skr59.58 Million
2018 11.94% 12.52% 0.57x 1.68x Skr12.78 Million
2019 7.15% 6.80% 0.59x 1.79x Skr-20.14 Million
2020 -1.31% -1.39% 0.51x 1.85x Skr-78.52 Million
2021 -7.29% -7.37% 0.37x 2.68x Skr-112.24 Million
2022 3.62% 2.82% 0.45x 2.85x Skr-41.94 Million
2023 11.09% 7.98% 0.52x 2.66x Skr8.05 Million
2024 23.21% 17.07% 0.57x 2.39x Skr115.84 Million

Industry Comparison

This section compares RaySearch Laboratories AB (publ)'s net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $146,825,819
  • Average return on equity (ROE) among peers: -122.62%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
RaySearch Laboratories AB (publ) (RAY-B) Skr919.30 Million -25.34% 1.11x $625.45 Million
Aino Health AB (AINO) $2.58 Million -590.61% 6.38x $3.08 Million
Carasent ASA (CARA) $808.00 Million 4.29% 0.16x $179.89 Million
Kontigo Care AB (KONT) $11.97 Million -119.33% 0.54x $6.54 Million
Medhelp Care AB (MEDHLP) $37.61 Million -20.92% 1.18x $22.60 Million
Physitrack PLC (PTRK) $1.19 Million -17.34% 0.70x $15.15 Million
Surgical Science Sweden AB (SUS) $19.60 Million 8.16% 1.79x $180.22 Million

About RaySearch Laboratories AB (publ)

ST:RAY-B Sweden Health Information Services
Market Cap
$625.45 Million
Skr5.81 Billion SEK
Market Cap Rank
#11392 Global
#178 in Sweden
Share Price
Skr188.70
Change (1 day)
+3.80%
52-Week Range
Skr168.40 - Skr365.50
All Time High
Skr365.50
About

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more